Neurofibromatosis type 1 (NF-1) is an autosomal dominant disorder characterized by cutaneous pigmentations, neurofibromas, Lisch nodules and neuroectodermal tumors. Supra-aortic vessel aneurysms may affect patients with NF-1 and can be associated with rupture, ischemic complications and compression symptoms. We describe a 48-year-old woman with NF-1 and an extracranial 3×5 cm right internal carotid artery aneurysm. After balloon test occlusion the patient was treated with parent artery sacrifice which led to significant shrinkage on follow-up MR and reduction of compression symptoms. The literature concerning internal carotid artery aneurysms associated with NF-1 is reviewed evaluating the possible therapeutic options.
National Institutes of Health consensus development conference: neurofibromatoses. Arch Neurol. 1988; 45: 575–578.
2.
OderichGSSullivanTMBowerTC. Vascular abnormalities in patients with neurofibromatosis syndrome type I: Clinical spectrum, management, and results. J Vasc Surg. 2007; 46: 475–484.
3.
HamiltonSJFriedmanJM. Insights into the pathogenesis of neurofibromatosis 1 vasculopathy. Clin Genet. 2000; 58: 341–344.
4.
DelisKTGloviczkiP. Neurofibromatosis type 1: from presentation and diagnosis to vascular and endovascular therapy. Perspect Vasc Surg Endovasc Ther. 2006; 18: 226–237.
5.
SeizingerBRRouleauGAOzeliusLJ. Genetic linkage of von Recklinghausen's neurofibromatosis to the nerve growth factor receptor gene. Cell1987; 49: 589–94.
6.
ZhaoJZHanXD. Cerebral aneurysm associated with von Recklinghausen's neurofibromatosis: a case report. Surg Neurol. 1998; 50 (6): 592–596.
7.
RasmussenSAYangQFriedmanJM. Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet. 2001; 68: 1110–1118.
8.
LiFMunchhofAMWhiteHA. Neurofibromin is a novel regulator of RAS- induced signals in primary vascular smooth muscle cells. Hum Mol Genet. 2006; 15: 1921–1930.
9.
LehrnbecherTGasselAMRauhV. Neurofibromatosis presenting as a severe systemic vasculopathy. Eur J Pediatr. 1994; 153: 107–109.
10.
ReubiF. Neurofibromatose et lesions vasculaires. Schweiz Med Wochenschr1945; 75: 463–465.
11.
HuffmanJLGahtanVBowersVD. Neurofibromatosis and arterial aneurysms. Am Surg. 1996; 62: 311–314.
12.
GreeneJFFitzwaterJEBurgessJ. Arterial lesions associated with neurofibromatosis. Am J Clin Pathol. 1974; 62: 481–487.
13.
HalpernMCurrarinoG. Vascular lesions causing hypertension in neurofibromatosis. N Engl J Med.1965: 273: 248–252.
14.
MalechaMJRubinR. Aneurysms of the carotid arteries associated with Von Recklinghausen's neurofibromatosis. Pathol Res Pract. 1992; 188: 145–147.
15.
SmithMAPWhiteJAM. Ruptured cervical aneurysm with neurofibromatosis. S Afr Med J.1974; 48: 945–946.
16.
FrankEBrownBMWilsonDF. Asymptomatic fusiform aneurysm of the petrous carotid artery in a patient with Von Recklinghausen's neurofibromatosis. Surg Neurol. 1989; 32: 75–78.
PourhassanSGrotemeyerDFokouM. Extracranial carotid arteries aneurysms in children: single-center experiences in 4 patients and review of the literature. J Pediatr Surg. 2007; 42: 1961–1968.
21.
OnkendiEMoghaddamMBOderichGS. Internal carotid artery aneurysms in a patient with neurofibromatosis type 1. Vasc Endovascular Surg. 2010; 44: 511–514.
BakoyiannisCNGeorgopoulosSETsekourasNS. Surgical management of extracranial internal carotid aneurysms by cervical approach. ANZ J Surg. 2006; 76: 612–617.
24.
MayJWhiteGHWaughR. Endoluminal repair of internal carotid artery aneurysm: a feasible but hazardous procedure. J Vasc Surg. 1997; 26: 1055–1060.
25.
SingerRJDabeMDNorbashA. Covered stent placement for neurovascular disease. Am J Neuroradiol. 1997; 18: 507–509.
26.
SmithBLMunschauerCEDiamondN. Ruptured internal carotid aneurysm resulting from neurofibromatosis: treatment with intraluminal stent graft. J Vasc Surg. 2000; 32: 824–828.
27.
TahaMMNakaharaIHigashiT. Interventional neuroradiological techniques for the treatment of aneurysms of the supra-aortic extracranial arteries. Neurol Med Chir (Tokyo). 2010; 50: 275–280.
28.
WeberWSiekmannRKisB. Treatment and follow-up of 22 unruptured wide-necked intracranial aneurysms of the internal carotid artery with Onyx HD 500. Am J Neuroradiol. 2005; 26: 1909–1915.
29.
ClarençonFBonnevilleFBochAL. Parent artery occlusion is not obsolete in giant aneurysms of the ICA. Experience with very-long-term follow-up. Neuroradiology. 2011; 53: 973–982.
30.
TatebeSAsamiFShinoharaH. Ruptured aneurysm of the subclavian artery in a patient with von Recklinghausen's disease. Circ J.2005; 69: 503–506.
31.
LarsonJJTewJMJrTomsickTA. Treatment of aneurysms of the internal carotid artery by intravascular balloon occlusion: Long-term follow-up of 58 patients. Neurosurgery. 1990; 36: 23–30.
32.
van der SchaafICBrilstraEHBuskensE. Endovascular treatment of aneurysms in the cavernous sinus: A systematic review on balloon occlusion of the parent vessel and embolization with coils. Stroke. 2002; 33: 313–318.
33.
van RooijWJSluzewskiM. Unruptured large and giant carotid artery aneurysms presenting with cranial nerve palsy: comparison of clinical recovery after selective aneurysm coiling and therapeutic carotid artery occlusion. Am J Neuroradiol. 2008; 29: 997–1002.
34.
de GastANSprengersMEvan RooijWJ. Midterm clinical and magnetic resonance imaging follow-up of large and giant carotid artery aneurysms after therapeutic carotid artery occlusion. Neurosurgery. 2007; 60: 1025–1029; discussion 1029–1031.
35.
NiiroMShimozuruTNakamuraK. Long-term follow-up study of patients with cavernous sinus aneurysm treated by proximal occlusion. Neurol Med Chir (Tokyo). 2000; 40: 88–96.
36.
de GastANSprengersMEvan RooijWJ. Long-term 3T MR angiography follow-up after therapeutic occlusion of the internal carotid artery to detect possible de novo aneurysm formation. Am J Neuroradiol. 2007; 28: 508–510.
37.
BoonLMMullikenJBVikkulaM. RASA 1: variable phenotype with capillary and arteriovenous malformations. Curr Opin Genet Dev.2005: 15: 265–269.
38.
RevencuNBoonLMMullikenJB. Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA 1 mutations. Hum Mutat. 2008: 29: 959–965.
